查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1876006

非处方皮肤科药物：全球市场份额和排名、总收入和需求预测（2025-2031年）

Dermatology OTC Medications - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
出版日期: | 出版商: QYResearch | 英文 143 Pages | 商品交期: 2-3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

全球非处方皮肤科市场预计在 2024 年达到 136.3 亿美元，预计到 2031 年将达到 170.5 亿美元，在预测期（2025-2031 年）内以 3.3% 的复合年增长率增长。

本报告对近期成药的关税调整和国际战略应对措施进行了全面评估，包括跨境产业布局、资本配置模式、区域经济相互依存关係和供应链重组。

非处方（OTC）皮肤科产品是指无需处方笺的药物，用于预防、控制和治疗常见的皮肤问题，包括痤疮、湿疹、皮肤炎、真菌感染疾病、皮肤干燥、晒伤和轻微伤口。这些产品在药局、超级市场和网路上均有贩售，包括乳霜、软膏、凝胶、乳液和药用洗面乳。它们通常含有水杨酸、过氧化苯甲酰、Hydrocortisone、抗真菌剂和抗组织胺药物活性成分，无需医生处方笺即可安全使用，为日常皮肤护理提供便捷且经济的解决方案。

市场竞争日趋激烈。拜耳、葛兰素史克、梯瓦、强生、诺华和迈兰等公司凭藉关键技术和专利，引领产业发展，并吸引高端客户。截至2019年，前五名厂商占据了25.08%的市场。

本报告旨在按地区/国家、类型和应用对全球皮肤科成药市场进行全面分析，重点关注总销售量、收入、价格、市场份额和主要企业的排名。

成药市场规模、估算和预测进行了呈现，基准年为2024年，并涵盖了2020年至2031年的历史数据和预测数据。报告采用定量和定性分析相结合的方法，帮助读者制定成药业务和成长策略，评估市场竞争，分析自身在当前市场中的地位，并做出明智的商业决策。

市场区隔

公司

  • Bayer
  • GSK
  • Teva
  • Johnson & Johnson
  • Novartis
  • Viatris
  • Sun Pharmaceutical
  • Aurobindo
  • Galderma
  • CR SANJIU
  • Dr. Reddy's
  • Lupin
  • Bausch Health
  • Cipla
  • Qilu Pharmaceutical
  • Almirall
  • Lingrui
  • Kaken Pharmaceutical
  • Jingwei Pharma
  • Zhiyuan Phamra

按类型分類的细分市场

  • 外用
  • 口服

应用领域

  • 医院
  • 药局
  • 其他的

按地区

  • 北美洲
    • 美国
    • 加拿大
  • 亚太地区
    • 中国
    • 日本
    • 韩国
    • 东南亚
    • 印度
    • 澳洲
    • 亚太其他地区
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 荷兰
    • 北欧国家
    • 其他欧洲
  • 拉丁美洲
    • 墨西哥
    • 巴西
    • 其他拉丁美洲
  • 中东和非洲
    • 土耳其
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 其他中东和非洲地区

The global market for Dermatology OTC Medications was estimated to be worth US$ 13630 million in 2024 and is forecast to a readjusted size of US$ 17050 million by 2031 with a CAGR of 3.3% during the forecast period 2025-2031.

This report provides a comprehensive assessment of recent tariff adjustments and international strategic countermeasures on Dermatology OTC Medications cross-border industrial footprints, capital allocation patterns, regional economic interdependencies, and supply chain reconfigurations.

Dermatology OTC (Over-the-Counter) medications refer to non-prescription drugs used to prevent, manage, or treat common skin conditions such as acne, eczema, dermatitis, fungal infections, dry skin, sunburn, and minor wounds. These products are widely available in pharmacies, supermarkets, and online, and include creams, ointments, gels, lotions, and medicated cleansers. They typically contain active ingredients like salicylic acid, benzoyl peroxide, hydrocortisone, antifungals, or antihistamines, and are designed for safe use without a doctor's prescription, offering convenient and cost-effective solutions for everyday dermatologic care.

Market competition is intense. Bayer, GSK, Teva, Johnson & Johnson, Novartis, Mylan, etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers. Top 5 manufacturers accounted for 25.08% market share in 2019.

This report aims to provide a comprehensive presentation of the global market for Dermatology OTC Medications, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Dermatology OTC Medications by region & country, by Type, and by Application.

The Dermatology OTC Medications market size, estimations, and forecasts are provided in terms of sales volume (M Units) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Dermatology OTC Medications.

Market Segmentation

By Company

  • Bayer
  • GSK
  • Teva
  • Johnson & Johnson
  • Novartis
  • Viatris
  • Sun Pharmaceutical
  • Aurobindo
  • Galderma
  • CR SANJIU
  • Dr. Reddy's
  • Lupin
  • Bausch Health
  • Cipla
  • Qilu Pharmaceutical
  • Almirall
  • Lingrui
  • Kaken Pharmaceutical
  • Jingwei Pharma
  • Zhiyuan Phamra

Segment by Type

  • External Use
  • Oral

Segment by Application

  • Hospital
  • Drug Store
  • Other

By Region

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Netherlands
    • Nordic Countries
    • Rest of Europe
  • Latin America
    • Mexico
    • Brazil
    • Rest of Latin America
  • Middle East & Africa
    • Turkey
    • Saudi Arabia
    • UAE
    • Rest of MEA

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 2: Detailed analysis of Dermatology OTC Medications manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Sales, revenue of Dermatology OTC Medications in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 6: Sales, revenue of Dermatology OTC Medications in country level. It provides sigmate data by Type, and by Application for each country/region.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 9: Conclusion.

Table of Contents

1 Market Overview

  • 1.1 Dermatology OTC Medications Product Introduction
  • 1.2 Global Dermatology OTC Medications Market Size Forecast
    • 1.2.1 Global Dermatology OTC Medications Sales Value (2020-2031)
    • 1.2.2 Global Dermatology OTC Medications Sales Volume (2020-2031)
    • 1.2.3 Global Dermatology OTC Medications Sales Price (2020-2031)
  • 1.3 Dermatology OTC Medications Market Trends & Drivers
    • 1.3.1 Dermatology OTC Medications Industry Trends
    • 1.3.2 Dermatology OTC Medications Market Drivers & Opportunity
    • 1.3.3 Dermatology OTC Medications Market Challenges
    • 1.3.4 Dermatology OTC Medications Market Restraints
  • 1.4 Assumptions and Limitations
  • 1.5 Study Objectives
  • 1.6 Years Considered

2 Competitive Analysis by Company

  • 2.1 Global Dermatology OTC Medications Players Revenue Ranking (2024)
  • 2.2 Global Dermatology OTC Medications Revenue by Company (2020-2025)
  • 2.3 Global Dermatology OTC Medications Players Sales Volume Ranking (2024)
  • 2.4 Global Dermatology OTC Medications Sales Volume by Company Players (2020-2025)
  • 2.5 Global Dermatology OTC Medications Average Price by Company (2020-2025)
  • 2.6 Key Manufacturers Dermatology OTC Medications Manufacturing Base and Headquarters
  • 2.7 Key Manufacturers Dermatology OTC Medications Product Offered
  • 2.8 Key Manufacturers Time to Begin Mass Production of Dermatology OTC Medications
  • 2.9 Dermatology OTC Medications Market Competitive Analysis
    • 2.9.1 Dermatology OTC Medications Market Concentration Rate (2020-2025)
    • 2.9.2 Global 5 and 10 Largest Manufacturers by Dermatology OTC Medications Revenue in 2024
    • 2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Dermatology OTC Medications as of 2024)
  • 2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type

  • 3.1 Introduction by Type
    • 3.1.1 External Use
    • 3.1.2 Oral
  • 3.2 Global Dermatology OTC Medications Sales Value by Type
    • 3.2.1 Global Dermatology OTC Medications Sales Value by Type (2020 VS 2024 VS 2031)
    • 3.2.2 Global Dermatology OTC Medications Sales Value, by Type (2020-2031)
    • 3.2.3 Global Dermatology OTC Medications Sales Value, by Type (%) (2020-2031)
  • 3.3 Global Dermatology OTC Medications Sales Volume by Type
    • 3.3.1 Global Dermatology OTC Medications Sales Volume by Type (2020 VS 2024 VS 2031)
    • 3.3.2 Global Dermatology OTC Medications Sales Volume, by Type (2020-2031)
    • 3.3.3 Global Dermatology OTC Medications Sales Volume, by Type (%) (2020-2031)
  • 3.4 Global Dermatology OTC Medications Average Price by Type (2020-2031)

4 Segmentation by Application

  • 4.1 Introduction by Application
    • 4.1.1 Hospital
    • 4.1.2 Drug Store
    • 4.1.3 Other
  • 4.2 Global Dermatology OTC Medications Sales Value by Application
    • 4.2.1 Global Dermatology OTC Medications Sales Value by Application (2020 VS 2024 VS 2031)
    • 4.2.2 Global Dermatology OTC Medications Sales Value, by Application (2020-2031)
    • 4.2.3 Global Dermatology OTC Medications Sales Value, by Application (%) (2020-2031)
  • 4.3 Global Dermatology OTC Medications Sales Volume by Application
    • 4.3.1 Global Dermatology OTC Medications Sales Volume by Application (2020 VS 2024 VS 2031)
    • 4.3.2 Global Dermatology OTC Medications Sales Volume, by Application (2020-2031)
    • 4.3.3 Global Dermatology OTC Medications Sales Volume, by Application (%) (2020-2031)
  • 4.4 Global Dermatology OTC Medications Average Price by Application (2020-2031)

5 Segmentation by Region

  • 5.1 Global Dermatology OTC Medications Sales Value by Region
    • 5.1.1 Global Dermatology OTC Medications Sales Value by Region: 2020 VS 2024 VS 2031
    • 5.1.2 Global Dermatology OTC Medications Sales Value by Region (2020-2025)
    • 5.1.3 Global Dermatology OTC Medications Sales Value by Region (2026-2031)
    • 5.1.4 Global Dermatology OTC Medications Sales Value by Region (%), (2020-2031)
  • 5.2 Global Dermatology OTC Medications Sales Volume by Region
    • 5.2.1 Global Dermatology OTC Medications Sales Volume by Region: 2020 VS 2024 VS 2031
    • 5.2.2 Global Dermatology OTC Medications Sales Volume by Region (2020-2025)
    • 5.2.3 Global Dermatology OTC Medications Sales Volume by Region (2026-2031)
    • 5.2.4 Global Dermatology OTC Medications Sales Volume by Region (%), (2020-2031)
  • 5.3 Global Dermatology OTC Medications Average Price by Region (2020-2031)
  • 5.4 North America
    • 5.4.1 North America Dermatology OTC Medications Sales Value, 2020-2031
    • 5.4.2 North America Dermatology OTC Medications Sales Value by Country (%), 2024 VS 2031
  • 5.5 Europe
    • 5.5.1 Europe Dermatology OTC Medications Sales Value, 2020-2031
    • 5.5.2 Europe Dermatology OTC Medications Sales Value by Country (%), 2024 VS 2031
  • 5.6 Asia Pacific
    • 5.6.1 Asia Pacific Dermatology OTC Medications Sales Value, 2020-2031
    • 5.6.2 Asia Pacific Dermatology OTC Medications Sales Value by Region (%), 2024 VS 2031
  • 5.7 South America
    • 5.7.1 South America Dermatology OTC Medications Sales Value, 2020-2031
    • 5.7.2 South America Dermatology OTC Medications Sales Value by Country (%), 2024 VS 2031
  • 5.8 Middle East & Africa
    • 5.8.1 Middle East & Africa Dermatology OTC Medications Sales Value, 2020-2031
    • 5.8.2 Middle East & Africa Dermatology OTC Medications Sales Value by Country (%), 2024 VS 2031

6 Segmentation by Key Countries/Regions

  • 6.1 Key Countries/Regions Dermatology OTC Medications Sales Value Growth Trends, 2020 VS 2024 VS 2031
  • 6.2 Key Countries/Regions Dermatology OTC Medications Sales Value and Sales Volume
    • 6.2.1 Key Countries/Regions Dermatology OTC Medications Sales Value, 2020-2031
    • 6.2.2 Key Countries/Regions Dermatology OTC Medications Sales Volume, 2020-2031
  • 6.3 United States
    • 6.3.1 United States Dermatology OTC Medications Sales Value, 2020-2031
    • 6.3.2 United States Dermatology OTC Medications Sales Value by Type (%), 2024 VS 2031
    • 6.3.3 United States Dermatology OTC Medications Sales Value by Application, 2024 VS 2031
  • 6.4 Europe
    • 6.4.1 Europe Dermatology OTC Medications Sales Value, 2020-2031
    • 6.4.2 Europe Dermatology OTC Medications Sales Value by Type (%), 2024 VS 2031
    • 6.4.3 Europe Dermatology OTC Medications Sales Value by Application, 2024 VS 2031
  • 6.5 China
    • 6.5.1 China Dermatology OTC Medications Sales Value, 2020-2031
    • 6.5.2 China Dermatology OTC Medications Sales Value by Type (%), 2024 VS 2031
    • 6.5.3 China Dermatology OTC Medications Sales Value by Application, 2024 VS 2031
  • 6.6 Japan
    • 6.6.1 Japan Dermatology OTC Medications Sales Value, 2020-2031
    • 6.6.2 Japan Dermatology OTC Medications Sales Value by Type (%), 2024 VS 2031
    • 6.6.3 Japan Dermatology OTC Medications Sales Value by Application, 2024 VS 2031
  • 6.7 South Korea
    • 6.7.1 South Korea Dermatology OTC Medications Sales Value, 2020-2031
    • 6.7.2 South Korea Dermatology OTC Medications Sales Value by Type (%), 2024 VS 2031
    • 6.7.3 South Korea Dermatology OTC Medications Sales Value by Application, 2024 VS 2031
  • 6.8 Southeast Asia
    • 6.8.1 Southeast Asia Dermatology OTC Medications Sales Value, 2020-2031
    • 6.8.2 Southeast Asia Dermatology OTC Medications Sales Value by Type (%), 2024 VS 2031
    • 6.8.3 Southeast Asia Dermatology OTC Medications Sales Value by Application, 2024 VS 2031
  • 6.9 India
    • 6.9.1 India Dermatology OTC Medications Sales Value, 2020-2031
    • 6.9.2 India Dermatology OTC Medications Sales Value by Type (%), 2024 VS 2031
    • 6.9.3 India Dermatology OTC Medications Sales Value by Application, 2024 VS 2031

7 Company Profiles

  • 7.1 Bayer
    • 7.1.1 Bayer Company Information
    • 7.1.2 Bayer Introduction and Business Overview
    • 7.1.3 Bayer Dermatology OTC Medications Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.1.4 Bayer Dermatology OTC Medications Product Offerings
    • 7.1.5 Bayer Recent Development
  • 7.2 GSK
    • 7.2.1 GSK Company Information
    • 7.2.2 GSK Introduction and Business Overview
    • 7.2.3 GSK Dermatology OTC Medications Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.2.4 GSK Dermatology OTC Medications Product Offerings
    • 7.2.5 GSK Recent Development
  • 7.3 Teva
    • 7.3.1 Teva Company Information
    • 7.3.2 Teva Introduction and Business Overview
    • 7.3.3 Teva Dermatology OTC Medications Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.3.4 Teva Dermatology OTC Medications Product Offerings
    • 7.3.5 Teva Recent Development
  • 7.4 Johnson & Johnson
    • 7.4.1 Johnson & Johnson Company Information
    • 7.4.2 Johnson & Johnson Introduction and Business Overview
    • 7.4.3 Johnson & Johnson Dermatology OTC Medications Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.4.4 Johnson & Johnson Dermatology OTC Medications Product Offerings
    • 7.4.5 Johnson & Johnson Recent Development
  • 7.5 Novartis
    • 7.5.1 Novartis Company Information
    • 7.5.2 Novartis Introduction and Business Overview
    • 7.5.3 Novartis Dermatology OTC Medications Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.5.4 Novartis Dermatology OTC Medications Product Offerings
    • 7.5.5 Novartis Recent Development
  • 7.6 Viatris
    • 7.6.1 Viatris Company Information
    • 7.6.2 Viatris Introduction and Business Overview
    • 7.6.3 Viatris Dermatology OTC Medications Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.6.4 Viatris Dermatology OTC Medications Product Offerings
    • 7.6.5 Viatris Recent Development
  • 7.7 Sun Pharmaceutical
    • 7.7.1 Sun Pharmaceutical Company Information
    • 7.7.2 Sun Pharmaceutical Introduction and Business Overview
    • 7.7.3 Sun Pharmaceutical Dermatology OTC Medications Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.7.4 Sun Pharmaceutical Dermatology OTC Medications Product Offerings
    • 7.7.5 Sun Pharmaceutical Recent Development
  • 7.8 Aurobindo
    • 7.8.1 Aurobindo Company Information
    • 7.8.2 Aurobindo Introduction and Business Overview
    • 7.8.3 Aurobindo Dermatology OTC Medications Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.8.4 Aurobindo Dermatology OTC Medications Product Offerings
    • 7.8.5 Aurobindo Recent Development
  • 7.9 Galderma
    • 7.9.1 Galderma Company Information
    • 7.9.2 Galderma Introduction and Business Overview
    • 7.9.3 Galderma Dermatology OTC Medications Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.9.4 Galderma Dermatology OTC Medications Product Offerings
    • 7.9.5 Galderma Recent Development
  • 7.10 CR SANJIU
    • 7.10.1 CR SANJIU Company Information
    • 7.10.2 CR SANJIU Introduction and Business Overview
    • 7.10.3 CR SANJIU Dermatology OTC Medications Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.10.4 CR SANJIU Dermatology OTC Medications Product Offerings
    • 7.10.5 CR SANJIU Recent Development
  • 7.11 Dr. Reddy's
    • 7.11.1 Dr. Reddy's Company Information
    • 7.11.2 Dr. Reddy's Introduction and Business Overview
    • 7.11.3 Dr. Reddy's Dermatology OTC Medications Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.11.4 Dr. Reddy's Dermatology OTC Medications Product Offerings
    • 7.11.5 Dr. Reddy's Recent Development
  • 7.12 Lupin
    • 7.12.1 Lupin Company Information
    • 7.12.2 Lupin Introduction and Business Overview
    • 7.12.3 Lupin Dermatology OTC Medications Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.12.4 Lupin Dermatology OTC Medications Product Offerings
    • 7.12.5 Lupin Recent Development
  • 7.13 Bausch Health
    • 7.13.1 Bausch Health Company Information
    • 7.13.2 Bausch Health Introduction and Business Overview
    • 7.13.3 Bausch Health Dermatology OTC Medications Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.13.4 Bausch Health Dermatology OTC Medications Product Offerings
    • 7.13.5 Bausch Health Recent Development
  • 7.14 Cipla
    • 7.14.1 Cipla Company Information
    • 7.14.2 Cipla Introduction and Business Overview
    • 7.14.3 Cipla Dermatology OTC Medications Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.14.4 Cipla Dermatology OTC Medications Product Offerings
    • 7.14.5 Cipla Recent Development
  • 7.15 Qilu Pharmaceutical
    • 7.15.1 Qilu Pharmaceutical Company Information
    • 7.15.2 Qilu Pharmaceutical Introduction and Business Overview
    • 7.15.3 Qilu Pharmaceutical Dermatology OTC Medications Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.15.4 Qilu Pharmaceutical Dermatology OTC Medications Product Offerings
    • 7.15.5 Qilu Pharmaceutical Recent Development
  • 7.16 Almirall
    • 7.16.1 Almirall Company Information
    • 7.16.2 Almirall Introduction and Business Overview
    • 7.16.3 Almirall Dermatology OTC Medications Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.16.4 Almirall Dermatology OTC Medications Product Offerings
    • 7.16.5 Almirall Recent Development
  • 7.17 Lingrui
    • 7.17.1 Lingrui Company Information
    • 7.17.2 Lingrui Introduction and Business Overview
    • 7.17.3 Lingrui Dermatology OTC Medications Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.17.4 Lingrui Dermatology OTC Medications Product Offerings
    • 7.17.5 Lingrui Recent Development
  • 7.18 Kaken Pharmaceutical
    • 7.18.1 Kaken Pharmaceutical Company Information
    • 7.18.2 Kaken Pharmaceutical Introduction and Business Overview
    • 7.18.3 Kaken Pharmaceutical Dermatology OTC Medications Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.18.4 Kaken Pharmaceutical Dermatology OTC Medications Product Offerings
    • 7.18.5 Kaken Pharmaceutical Recent Development
  • 7.19 Jingwei Pharma
    • 7.19.1 Jingwei Pharma Company Information
    • 7.19.2 Jingwei Pharma Introduction and Business Overview
    • 7.19.3 Jingwei Pharma Dermatology OTC Medications Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.19.4 Jingwei Pharma Dermatology OTC Medications Product Offerings
    • 7.19.5 Jingwei Pharma Recent Development
  • 7.20 Zhiyuan Phamra
    • 7.20.1 Zhiyuan Phamra Company Information
    • 7.20.2 Zhiyuan Phamra Introduction and Business Overview
    • 7.20.3 Zhiyuan Phamra Dermatology OTC Medications Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.20.4 Zhiyuan Phamra Dermatology OTC Medications Product Offerings
    • 7.20.5 Zhiyuan Phamra Recent Development

8 Industry Chain Analysis

  • 8.1 Dermatology OTC Medications Industrial Chain
  • 8.2 Dermatology OTC Medications Upstream Analysis
    • 8.2.1 Key Raw Materials
    • 8.2.2 Raw Materials Key Suppliers
    • 8.2.3 Manufacturing Cost Structure
  • 8.3 Midstream Analysis
  • 8.4 Downstream Analysis (Customers Analysis)
  • 8.5 Sales Model and Sales Channels
    • 8.5.1 Dermatology OTC Medications Sales Model
    • 8.5.2 Sales Channel
    • 8.5.3 Dermatology OTC Medications Distributors

9 Research Findings and Conclusion

10 Appendix

  • 10.1 Research Methodology
    • 10.1.1 Methodology/Research Approach
      • 10.1.1.1 Research Programs/Design
      • 10.1.1.2 Market Size Estimation
      • 10.1.1.3 Market Breakdown and Data Triangulation
    • 10.1.2 Data Source
      • 10.1.2.1 Secondary Sources
      • 10.1.2.2 Primary Sources
  • 10.2 Author Details
  • 10.3 Disclaimer

List of Tables

  • Table 1. Dermatology OTC Medications Market Trends
  • Table 2. Dermatology OTC Medications Market Drivers & Opportunity
  • Table 3. Dermatology OTC Medications Market Challenges
  • Table 4. Dermatology OTC Medications Market Restraints
  • Table 5. Global Dermatology OTC Medications Revenue by Company (2020-2025) & (US$ Million)
  • Table 6. Global Dermatology OTC Medications Revenue Market Share by Company (2020-2025)
  • Table 7. Global Dermatology OTC Medications Sales Volume by Company (2020-2025) & (M Units)
  • Table 8. Global Dermatology OTC Medications Sales Volume Market Share by Company (2020-2025)
  • Table 9. Global Market Dermatology OTC Medications Price by Company (2020-2025) & (USD/Unit)
  • Table 10. Key Manufacturers Dermatology OTC Medications Manufacturing Base and Headquarters
  • Table 11. Key Manufacturers Dermatology OTC Medications Product Type
  • Table 12. Key Manufacturers Time to Begin Mass Production of Dermatology OTC Medications
  • Table 13. Global Dermatology OTC Medications Manufacturers Market Concentration Ratio (CR5 and HHI)
  • Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Dermatology OTC Medications as of 2024)
  • Table 15. Mergers & Acquisitions, Expansion Plans
  • Table 16. Global Dermatology OTC Medications Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)
  • Table 17. Global Dermatology OTC Medications Sales Value by Type (2020-2025) & (US$ Million)
  • Table 18. Global Dermatology OTC Medications Sales Value by Type (2026-2031) & (US$ Million)
  • Table 19. Global Dermatology OTC Medications Sales Market Share in Value by Type (2020-2025)
  • Table 20. Global Dermatology OTC Medications Sales Market Share in Value by Type (2026-2031)
  • Table 21. Global Dermatology OTC Medications Sales Volume by Type: 2020 VS 2024 VS 2031 (M Units)
  • Table 22. Global Dermatology OTC Medications Sales Volume by Type (2020-2025) & (M Units)
  • Table 23. Global Dermatology OTC Medications Sales Volume by Type (2026-2031) & (M Units)
  • Table 24. Global Dermatology OTC Medications Sales Market Share in Volume by Type (2020-2025)
  • Table 25. Global Dermatology OTC Medications Sales Market Share in Volume by Type (2026-2031)
  • Table 26. Global Dermatology OTC Medications Price by Type (2020-2025) & (USD/Unit)
  • Table 27. Global Dermatology OTC Medications Price by Type (2026-2031) & (USD/Unit)
  • Table 28. Global Dermatology OTC Medications Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)
  • Table 29. Global Dermatology OTC Medications Sales Value by Application (2020-2025) & (US$ Million)
  • Table 30. Global Dermatology OTC Medications Sales Value by Application (2026-2031) & (US$ Million)
  • Table 31. Global Dermatology OTC Medications Sales Market Share in Value by Application (2020-2025)
  • Table 32. Global Dermatology OTC Medications Sales Market Share in Value by Application (2026-2031)
  • Table 33. Global Dermatology OTC Medications Sales Volume by Application: 2020 VS 2024 VS 2031 (M Units)
  • Table 34. Global Dermatology OTC Medications Sales Volume by Application (2020-2025) & (M Units)
  • Table 35. Global Dermatology OTC Medications Sales Volume by Application (2026-2031) & (M Units)
  • Table 36. Global Dermatology OTC Medications Sales Market Share in Volume by Application (2020-2025)
  • Table 37. Global Dermatology OTC Medications Sales Market Share in Volume by Application (2026-2031)
  • Table 38. Global Dermatology OTC Medications Price by Application (2020-2025) & (USD/Unit)
  • Table 39. Global Dermatology OTC Medications Price by Application (2026-2031) & (USD/Unit)
  • Table 40. Global Dermatology OTC Medications Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)
  • Table 41. Global Dermatology OTC Medications Sales Value by Region (2020-2025) & (US$ Million)
  • Table 42. Global Dermatology OTC Medications Sales Value by Region (2026-2031) & (US$ Million)
  • Table 43. Global Dermatology OTC Medications Sales Value by Region (2020-2025) & (%)
  • Table 44. Global Dermatology OTC Medications Sales Value by Region (2026-2031) & (%)
  • Table 45. Global Dermatology OTC Medications Sales Volume by Region (M Units): 2020 VS 2024 VS 2031
  • Table 46. Global Dermatology OTC Medications Sales Volume by Region (2020-2025) & (M Units)
  • Table 47. Global Dermatology OTC Medications Sales Volume by Region (2026-2031) & (M Units)
  • Table 48. Global Dermatology OTC Medications Sales Volume by Region (2020-2025) & (%)
  • Table 49. Global Dermatology OTC Medications Sales Volume by Region (2026-2031) & (%)
  • Table 50. Global Dermatology OTC Medications Average Price by Region (2020-2025) & (USD/Unit)
  • Table 51. Global Dermatology OTC Medications Average Price by Region (2026-2031) & (USD/Unit)
  • Table 52. Key Countries/Regions Dermatology OTC Medications Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031
  • Table 53. Key Countries/Regions Dermatology OTC Medications Sales Value, (2020-2025) & (US$ Million)
  • Table 54. Key Countries/Regions Dermatology OTC Medications Sales Value, (2026-2031) & (US$ Million)
  • Table 55. Key Countries/Regions Dermatology OTC Medications Sales Volume, (2020-2025) & (M Units)
  • Table 56. Key Countries/Regions Dermatology OTC Medications Sales Volume, (2026-2031) & (M Units)
  • Table 57. Bayer Company Information
  • Table 58. Bayer Introduction and Business Overview
  • Table 59. Bayer Dermatology OTC Medications Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
  • Table 60. Bayer Dermatology OTC Medications Product Offerings
  • Table 61. Bayer Recent Development
  • Table 62. GSK Company Information
  • Table 63. GSK Introduction and Business Overview
  • Table 64. GSK Dermatology OTC Medications Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
  • Table 65. GSK Dermatology OTC Medications Product Offerings
  • Table 66. GSK Recent Development
  • Table 67. Teva Company Information
  • Table 68. Teva Introduction and Business Overview
  • Table 69. Teva Dermatology OTC Medications Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
  • Table 70. Teva Dermatology OTC Medications Product Offerings
  • Table 71. Teva Recent Development
  • Table 72. Johnson & Johnson Company Information
  • Table 73. Johnson & Johnson Introduction and Business Overview
  • Table 74. Johnson & Johnson Dermatology OTC Medications Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
  • Table 75. Johnson & Johnson Dermatology OTC Medications Product Offerings
  • Table 76. Johnson & Johnson Recent Development
  • Table 77. Novartis Company Information
  • Table 78. Novartis Introduction and Business Overview
  • Table 79. Novartis Dermatology OTC Medications Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
  • Table 80. Novartis Dermatology OTC Medications Product Offerings
  • Table 81. Novartis Recent Development
  • Table 82. Viatris Company Information
  • Table 83. Viatris Introduction and Business Overview
  • Table 84. Viatris Dermatology OTC Medications Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
  • Table 85. Viatris Dermatology OTC Medications Product Offerings
  • Table 86. Viatris Recent Development
  • Table 87. Sun Pharmaceutical Company Information
  • Table 88. Sun Pharmaceutical Introduction and Business Overview
  • Table 89. Sun Pharmaceutical Dermatology OTC Medications Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
  • Table 90. Sun Pharmaceutical Dermatology OTC Medications Product Offerings
  • Table 91. Sun Pharmaceutical Recent Development
  • Table 92. Aurobindo Company Information
  • Table 93. Aurobindo Introduction and Business Overview
  • Table 94. Aurobindo Dermatology OTC Medications Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
  • Table 95. Aurobindo Dermatology OTC Medications Product Offerings
  • Table 96. Aurobindo Recent Development
  • Table 97. Galderma Company Information
  • Table 98. Galderma Introduction and Business Overview
  • Table 99. Galderma Dermatology OTC Medications Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
  • Table 100. Galderma Dermatology OTC Medications Product Offerings
  • Table 101. Galderma Recent Development
  • Table 102. CR SANJIU Company Information
  • Table 103. CR SANJIU Introduction and Business Overview
  • Table 104. CR SANJIU Dermatology OTC Medications Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
  • Table 105. CR SANJIU Dermatology OTC Medications Product Offerings
  • Table 106. CR SANJIU Recent Development
  • Table 107. Dr. Reddy's Company Information
  • Table 108. Dr. Reddy's Introduction and Business Overview
  • Table 109. Dr. Reddy's Dermatology OTC Medications Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
  • Table 110. Dr. Reddy's Dermatology OTC Medications Product Offerings
  • Table 111. Dr. Reddy's Recent Development
  • Table 112. Lupin Company Information
  • Table 113. Lupin Introduction and Business Overview
  • Table 114. Lupin Dermatology OTC Medications Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
  • Table 115. Lupin Dermatology OTC Medications Product Offerings
  • Table 116. Lupin Recent Development
  • Table 117. Bausch Health Company Information
  • Table 118. Bausch Health Introduction and Business Overview
  • Table 119. Bausch Health Dermatology OTC Medications Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
  • Table 120. Bausch Health Dermatology OTC Medications Product Offerings
  • Table 121. Bausch Health Recent Development
  • Table 122. Cipla Company Information
  • Table 123. Cipla Introduction and Business Overview
  • Table 124. Cipla Dermatology OTC Medications Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
  • Table 125. Cipla Dermatology OTC Medications Product Offerings
  • Table 126. Cipla Recent Development
  • Table 127. Qilu Pharmaceutical Company Information
  • Table 128. Qilu Pharmaceutical Introduction and Business Overview
  • Table 129. Qilu Pharmaceutical Dermatology OTC Medications Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
  • Table 130. Qilu Pharmaceutical Dermatology OTC Medications Product Offerings
  • Table 131. Qilu Pharmaceutical Recent Development
  • Table 132. Almirall Company Information
  • Table 133. Almirall Introduction and Business Overview
  • Table 134. Almirall Dermatology OTC Medications Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
  • Table 135. Almirall Dermatology OTC Medications Product Offerings
  • Table 136. Almirall Recent Development
  • Table 137. Lingrui Company Information
  • Table 138. Lingrui Introduction and Business Overview
  • Table 139. Lingrui Dermatology OTC Medications Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
  • Table 140. Lingrui Dermatology OTC Medications Product Offerings
  • Table 141. Lingrui Recent Development
  • Table 142. Kaken Pharmaceutical Company Information
  • Table 143. Kaken Pharmaceutical Introduction and Business Overview
  • Table 144. Kaken Pharmaceutical Dermatology OTC Medications Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
  • Table 145. Kaken Pharmaceutical Dermatology OTC Medications Product Offerings
  • Table 146. Kaken Pharmaceutical Recent Development
  • Table 147. Jingwei Pharma Company Information
  • Table 148. Jingwei Pharma Introduction and Business Overview
  • Table 149. Jingwei Pharma Dermatology OTC Medications Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
  • Table 150. Jingwei Pharma Dermatology OTC Medications Product Offerings
  • Table 151. Jingwei Pharma Recent Development
  • Table 152. Zhiyuan Phamra Company Information
  • Table 153. Zhiyuan Phamra Introduction and Business Overview
  • Table 154. Zhiyuan Phamra Dermatology OTC Medications Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
  • Table 155. Zhiyuan Phamra Dermatology OTC Medications Product Offerings
  • Table 156. Zhiyuan Phamra Recent Development
  • Table 157. Key Raw Materials Lists
  • Table 158. Raw Materials Key Suppliers Lists
  • Table 159. Dermatology OTC Medications Downstream Customers
  • Table 160. Dermatology OTC Medications Distributors List
  • Table 161. Research Programs/Design for This Report
  • Table 162. Key Data Information from Secondary Sources
  • Table 163. Key Data Information from Primary Sources

List of Figures

  • Figure 1. Dermatology OTC Medications Product Picture
  • Figure 2. Global Dermatology OTC Medications Sales Value, 2020 VS 2024 VS 2031 (US$ Million)
  • Figure 3. Global Dermatology OTC Medications Sales Value (2020-2031) & (US$ Million)
  • Figure 4. Global Dermatology OTC Medications Sales Volume (2020-2031) & (M Units)
  • Figure 5. Global Dermatology OTC Medications Sales Price (2020-2031) & (USD/Unit)
  • Figure 6. Dermatology OTC Medications Report Years Considered
  • Figure 7. Global Dermatology OTC Medications Players Revenue Ranking (2024) & (US$ Million)
  • Figure 8. Global Dermatology OTC Medications Players Sales Volume Ranking (2024) & (M Units)
  • Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Dermatology OTC Medications Revenue in 2024
  • Figure 10. Dermatology OTC Medications Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
  • Figure 11. External Use Picture
  • Figure 12. Oral Picture
  • Figure 13. Global Dermatology OTC Medications Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)
  • Figure 14. Global Dermatology OTC Medications Sales Value Market Share by Type, 2024 & 2031
  • Figure 15. Global Dermatology OTC Medications Sales Volume by Type (2020 VS 2024 VS 2031) & (M Units)
  • Figure 16. Global Dermatology OTC Medications Sales Volume Market Share by Type, 2024 & 2031
  • Figure 17. Global Dermatology OTC Medications Price by Type (2020-2031) & (USD/Unit)
  • Figure 18. Product Picture of Hospital
  • Figure 19. Product Picture of Drug Store
  • Figure 20. Product Picture of Other
  • Figure 21. Global Dermatology OTC Medications Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)
  • Figure 22. Global Dermatology OTC Medications Sales Value Market Share by Application, 2024 & 2031
  • Figure 23. Global Dermatology OTC Medications Sales Volume by Application (2020 VS 2024 VS 2031) & (M Units)
  • Figure 24. Global Dermatology OTC Medications Sales Volume Market Share by Application, 2024 & 2031
  • Figure 25. Global Dermatology OTC Medications Price by Application (2020-2031) & (USD/Unit)
  • Figure 26. North America Dermatology OTC Medications Sales Value (2020-2031) & (US$ Million)
  • Figure 27. North America Dermatology OTC Medications Sales Value by Country (%), 2024 VS 2031
  • Figure 28. Europe Dermatology OTC Medications Sales Value, (2020-2031) & (US$ Million)
  • Figure 29. Europe Dermatology OTC Medications Sales Value by Country (%), 2024 VS 2031
  • Figure 30. Asia Pacific Dermatology OTC Medications Sales Value, (2020-2031) & (US$ Million)
  • Figure 31. Asia Pacific Dermatology OTC Medications Sales Value by Region (%), 2024 VS 2031
  • Figure 32. South America Dermatology OTC Medications Sales Value, (2020-2031) & (US$ Million)
  • Figure 33. South America Dermatology OTC Medications Sales Value by Country (%), 2024 VS 2031
  • Figure 34. Middle East & Africa Dermatology OTC Medications Sales Value, (2020-2031) & (US$ Million)
  • Figure 35. Middle East & Africa Dermatology OTC Medications Sales Value by Country (%), 2024 VS 2031
  • Figure 36. Key Countries/Regions Dermatology OTC Medications Sales Value (%), (2020-2031)
  • Figure 37. Key Countries/Regions Dermatology OTC Medications Sales Volume (%), (2020-2031)
  • Figure 38. United States Dermatology OTC Medications Sales Value, (2020-2031) & (US$ Million)
  • Figure 39. United States Dermatology OTC Medications Sales Value by Type (%), 2024 VS 2031
  • Figure 40. United States Dermatology OTC Medications Sales Value by Application (%), 2024 VS 2031
  • Figure 41. Europe Dermatology OTC Medications Sales Value, (2020-2031) & (US$ Million)
  • Figure 42. Europe Dermatology OTC Medications Sales Value by Type (%), 2024 VS 2031
  • Figure 43. Europe Dermatology OTC Medications Sales Value by Application (%), 2024 VS 2031
  • Figure 44. China Dermatology OTC Medications Sales Value, (2020-2031) & (US$ Million)
  • Figure 45. China Dermatology OTC Medications Sales Value by Type (%), 2024 VS 2031
  • Figure 46. China Dermatology OTC Medications Sales Value by Application (%), 2024 VS 2031
  • Figure 47. Japan Dermatology OTC Medications Sales Value, (2020-2031) & (US$ Million)
  • Figure 48. Japan Dermatology OTC Medications Sales Value by Type (%), 2024 VS 2031
  • Figure 49. Japan Dermatology OTC Medications Sales Value by Application (%), 2024 VS 2031
  • Figure 50. South Korea Dermatology OTC Medications Sales Value, (2020-2031) & (US$ Million)
  • Figure 51. South Korea Dermatology OTC Medications Sales Value by Type (%), 2024 VS 2031
  • Figure 52. South Korea Dermatology OTC Medications Sales Value by Application (%), 2024 VS 2031
  • Figure 53. Southeast Asia Dermatology OTC Medications Sales Value, (2020-2031) & (US$ Million)
  • Figure 54. Southeast Asia Dermatology OTC Medications Sales Value by Type (%), 2024 VS 2031
  • Figure 55. Southeast Asia Dermatology OTC Medications Sales Value by Application (%), 2024 VS 2031
  • Figure 56. India Dermatology OTC Medications Sales Value, (2020-2031) & (US$ Million)
  • Figure 57. India Dermatology OTC Medications Sales Value by Type (%), 2024 VS 2031
  • Figure 58. India Dermatology OTC Medications Sales Value by Application (%), 2024 VS 2031
  • Figure 59. Dermatology OTC Medications Industrial Chain
  • Figure 60. Dermatology OTC Medications Manufacturing Cost Structure
  • Figure 61. Channels of Distribution (Direct Sales, and Distribution)
  • Figure 62. Bottom-up and Top-down Approaches for This Report
  • Figure 63. Data Triangulation
  • Figure 64. Key Executives Interviewed